Bank Of America Corp Halozyme Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,314,062 shares of HALO stock, worth $123 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,314,062

Previous 3,448,387 32.89%

Holding current value

$123 Million

Previous $165 Million 10.44%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$47.74 - $65.16 $54.2 Million - $73.9 Million	-1,134,325 Reduced 32.89%	2,314,062 $148 Million
Q4 2024 Feb 14, 2025	BUY	$42.57 - $61.09 $58.7 Million - $84.2 Million	1,378,955 Added 66.63%	3,448,387 $165 Million
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $12.5 Million - $15.7 Million	243,776 Added 13.35%	2,069,432 $118 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $4.86 Million - $6.73 Million	128,504 Added 7.57%	1,825,656 $95.6 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $17.2 Million - $21.4 Million	509,493 Added 42.9%	1,697,152 $69 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $2.22 Million - $2.8 Million	66,511 Added 5.93%	1,187,659 $43.9 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $11.4 Million - $14.5 Million	-375,408 Reduced 25.08%	1,121,148 $40.4 Million
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $13.9 Million - $23.6 Million	422,949 Added 39.4%	1,496,556 $57.2 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $2.24 Million - $3.32 Million	-55,937 Reduced 4.95%	1,073,607 $61.1 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $14.4 Million - $19.4 Million	375,019 Added 49.7%	1,129,544 $44.7 Million
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $981,296 - $1.27 Million	26,273 Added 3.61%	754,525 $33.2 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $2.38 Million - $3.05 Million	74,395 Added 11.38%	728,252 $29 Million
Q4 2021 Feb 08, 2022	SELL	$31.82 - $40.75 $2.51 Million - $3.21 Million	-78,841 Reduced 10.76%	653,857 $26.3 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $2.19 Million - $2.65 Million	57,050 Added 8.44%	732,698 $29.8 Million
Q2 2021 Sep 13, 2021	BUY	$38.84 - $51.31 $26.2 Million - $34.7 Million	675,648 New	675,648 $30.7 Million

Others Institutions Holding HALO

# of Institutions

594

Shares Held

124M

Call Options Held

320K

Put Options Held

113K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.42B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Halozyme Therapeutics, Inc. Transaction History